Swedish drugmaker Meda spurns Mylan takeover approach

STOCKHOLM (Reuters) - Sweden's Meda AB said on Friday it had rejected a takeover approach by U.S. generic drugmaker Mylan Inc, scuppering a potential deal to create a combined company worth around...

from Reuters: Deals http://ift.tt/1q5Zsos